Drug recall · June 20, 2012
Propofol Injectable Emulsion recall
Why: Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.
- Lots / codes
Lot #: a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013; Note: * the lot may be followed by 01.
- Quantity
- a) 36,125 vials; b) 31,280 vials
- Company
- Hospira, Inc., Lake Forest, IL
- Distribution
- Nationwide.
- Initiated
- April 11, 2012 · Voluntary: Firm initiated
- Classified
- June 14, 2012
- Reported
- June 20, 2012
- Ended
- June 27, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Propofol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.